Interestingly, intra-mPFC administration of oxytocin induce a significant increase of Claudin-5 protein levels accompanied with a reduction of EB staining that can reduce epilepsy development and improve cognitive impairments. This evidence concerns the gene CLDN5 and Cognitive impairment.